Blue Sail Medical Co Ltd (002382) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.007x

Based on the latest financial reports, Blue Sail Medical Co Ltd (002382) has a cash flow conversion efficiency ratio of -0.007x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-63.13 Million ≈ $-9.24 Million USD) by net assets (CN¥9.71 Billion ≈ $1.42 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Blue Sail Medical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Blue Sail Medical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Blue Sail Medical Co Ltd for a breakdown of total debt and financial obligations.

Blue Sail Medical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Blue Sail Medical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Netcare
JSE:NTC
0.220x
Karoon Energy Ltd
AU:KAR
0.165x
SFL Corporation Ltd
NYSE:SFL
0.067x
Jiangsu Transimage Technology Co Ltd
SHE:002866
0.011x
Trican Well Service Ltd.
TO:TCW
0.127x
Oric Pharmaceuticals Inc
NASDAQ:ORIC
-0.058x
SBFC Finance Limited
NSE:SBFC
-0.243x
T1 Energy Inc.
NYSE:TE
0.410x

Annual Cash Flow Conversion Efficiency for Blue Sail Medical Co Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Blue Sail Medical Co Ltd from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see Blue Sail Medical Co Ltd (002382) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥9.80 Billion
≈ $1.43 Billion
CN¥135.85 Million
≈ $19.88 Million
0.014x +281.59%
2023-12-31 CN¥9.55 Billion
≈ $1.40 Billion
CN¥-72.89 Million
≈ $-10.67 Million
-0.008x -116.29%
2022-12-31 CN¥10.55 Billion
≈ $1.54 Billion
CN¥494.47 Million
≈ $72.36 Million
0.047x -78.01%
2021-12-31 CN¥10.54 Billion
≈ $1.54 Billion
CN¥2.25 Billion
≈ $328.59 Million
0.213x -43.01%
2020-12-31 CN¥9.82 Billion
≈ $1.44 Billion
CN¥3.67 Billion
≈ $537.26 Million
0.374x +304.35%
2019-12-31 CN¥8.46 Billion
≈ $1.24 Billion
CN¥782.79 Million
≈ $114.55 Million
0.092x +11.09%
2018-12-31 CN¥7.80 Billion
≈ $1.14 Billion
CN¥649.37 Million
≈ $95.02 Million
0.083x -47.75%
2017-12-31 CN¥1.43 Billion
≈ $209.01 Million
CN¥227.57 Million
≈ $33.30 Million
0.159x +26.35%
2016-12-31 CN¥1.30 Billion
≈ $190.24 Million
CN¥163.93 Million
≈ $23.99 Million
0.126x -42.87%
2015-12-31 CN¥1.18 Billion
≈ $173.22 Million
CN¥261.30 Million
≈ $38.24 Million
0.221x +52.92%
2014-12-31 CN¥1.05 Billion
≈ $153.03 Million
CN¥150.96 Million
≈ $22.09 Million
0.144x +6.12%
2013-12-31 CN¥984.34 Million
≈ $144.04 Million
CN¥133.89 Million
≈ $19.59 Million
0.136x -14.95%
2012-12-31 CN¥961.83 Million
≈ $140.75 Million
CN¥153.82 Million
≈ $22.51 Million
0.160x +322.70%
2011-12-31 CN¥916.68 Million
≈ $134.14 Million
CN¥-65.83 Million
≈ $-9.63 Million
-0.072x -105.01%
2010-12-31 CN¥903.72 Million
≈ $132.24 Million
CN¥-31.66 Million
≈ $-4.63 Million
-0.035x -111.47%
2009-12-31 CN¥203.26 Million
≈ $29.74 Million
CN¥62.05 Million
≈ $9.08 Million
0.305x -36.30%
2008-12-31 CN¥158.41 Million
≈ $23.18 Million
CN¥75.91 Million
≈ $11.11 Million
0.479x +189.28%
2007-12-31 CN¥97.05 Million
≈ $14.20 Million
CN¥16.08 Million
≈ $2.35 Million
0.166x +8.71%
2006-12-31 CN¥78.81 Million
≈ $11.53 Million
CN¥12.01 Million
≈ $1.76 Million
0.152x --

About Blue Sail Medical Co Ltd

SHE:002382 China Medical Instruments & Supplies
Market Cap
$1.10 Billion
CN¥7.48 Billion CNY
Market Cap Rank
#8716 Global
#2293 in China
Share Price
CN¥7.43
Change (1 day)
+1.92%
52-Week Range
CN¥5.10 - CN¥8.66
All Time High
CN¥34.79
About

Blue Sail Medical Co.,Ltd. operates as a medical device company in China and internationally. It operates through Health Protection Division; Cardiovascular and Cerebrovascular Department; and Emergency Rescue Division segments. The company offers cardiovascular and cerebrovascular products comprising drug-eluting stents and balloons, conventional balloons, and transcatheter aortic valve replacem… Read more